Carbonic anhydrase II (CA II) is a zinc metalloenzyme that catalyzes the reversible interconversion of water and CO 2 to bicarbonate and a proton. CA II is abundant in most cells, and plays a role in numerous processes including gas exchange, epithelial ion transport, respiration, extra-and intracellular pH control, and vascular regulation. Beyond these CO 2 and pH-linked roles, it has been postulated that CA II might also reduce nitrite (NO 2 -) to nitric oxide (NO), as bicarbonate and NO 2 -both exhibit sp 2 molecular geometry and NO also plays an important role in vasodilation and regulation of blood pressure. . Hence, the goal of this work was to revisit these studies using the same experimental conditions as Aamand et al. measuring NO generation by two methods, and to examine the structure of CA II in complex with NO 2 -in the presence and absence of dorzolamide. Our results contradict the previous findings and indicate that CA II does not exhibit nitrite reductase or dehydration activity, and that this is not enhanced in the presence of CA inhibitors. In addition, a structural examination of BCA II in complex with NO 2 -and superimposed with dorzolamide demonstrates that CA inhibitor binding at the active site to the zinc moiety blocks potential NO 2 -binding.
A B S T R A C T
Carbonic anhydrase II (CA II) is a zinc metalloenzyme that catalyzes the reversible interconversion of water and CO 2 to bicarbonate and a proton. CA II is abundant in most cells, and plays a role in numerous processes including gas exchange, epithelial ion transport, respiration, extra-and intracellular pH control, and vascular regulation. Beyond these CO 2 and pH-linked roles, it has been postulated that CA II might also reduce nitrite (NO 2 -) to nitric oxide (NO), as bicarbonate and NO 2 -both exhibit sp 2 molecular geometry and NO also plays an important role in vasodilation and regulation of blood pressure. Indeed, previous studies by Aamand et al. have shown that bovine CA II (BCA II) possesses nitrite dehydration activity and paradoxically demonstrated that CA inhibitors (CAIs) such as dorzolamide and acetazolamide significantly increased NO production (Aamand et al., 2009; Nielsen and Fago, 2015) [1, 2] . Hence, the goal of this work was to revisit these studies using the same experimental conditions as Aamand et al. measuring NO generation by two methods, and to examine the structure of CA II in complex with NO 2 -in the presence and absence of dorzolamide. Our results contradict the previous findings and indicate that CA II does not exhibit nitrite reductase or dehydration activity, and that this is not enhanced in the presence of CA inhibitors. In addition, a structural examination of BCA II in complex with NO 2 -and superimposed with dorzolamide demonstrates that CA inhibitor binding at the active site to the zinc moiety blocks potential NO 2 -binding.
Introduction
Nitric oxide (NO) is an important mediator in cell signaling events that regulate vascular tone. The generation of NO promotes vasodilation through the binding and activation of guanylate cyclase, subsequently increasing the concentration of cyclic GMP. This results in a decrease in intracellular calcium concentration and causes the relaxation of smooth muscle and reduction of blood pressure [3] [4] [5] . Endothelial production of NO has been documented to mediate 25-30% of basal human blood pressure [6] . NO also plays a role in other physiological processes, such as inhibition of platelet aggregation, gene transcription regulation, and protein post-translational modification [7] .
The most physiologically relevant source of NO is synthesis by endothelial nitrogen oxide synthase (eNOS), an enzyme which catalyzes the oxidation of arginine to produce NO and citrulline [3, 8] . The eNOS catalytic mechanism consists of a succession of two monooxygenase reactions that use NADPH as an electron source. The guanidino nitrogen of arginine is first oxidized, followed by the oxidation of NOH in the NOH-Arg intermediate [8] . While arginine is the main source of NO, nitrite is known to be a secondary source of NO through metalloenzyme mediated reduction. Multiple copper and iron containing enzymes, not found in humans, are known to efficiently reduce nitrite via electron donation from the coordinated metal ion. These include copper-containing nitrite reductase and ferredoxin-nitrite reductase, both known to be highly conserved and important in the nitrogen cycle [9, 10] . Humans and other mammals largely depend on bacteria living in the GI tract to reduce nitrite to NO [11] . While humans do not have an enzyme specifically dedicated to nitrite reduction, several metalloenzymes exhibit nitrite reductase activity in hypoxic conditions [12] . Globin proteins with coordinated iron atoms, such as hemoglobin, myoglobin, and neuroglobin, have been shown to trigger hypoxic vasodilation through the generation of NO and induce large downstream signaling [12] . Several other proteins, such as cytochrome c, aldehyde oxidase, and xanthine oxidoreductase, have also been shown to reduce nitrite through redox reactions important to the function of mitochondria [13] [14] [15] . In the past several years, multiple groups have maintained that the carbonic anhydrase family of metalloenzymes may also play a role in NO generation [1, 2] .
Aamand et al. proposed that human carbonic anhydrase II (CA II) can generate NO, owing to the structural similarity between bicarbonate and nitrite [1] . Human CA II is a zinc metalloenzyme that catalyzes the reversible interconversion of carbon dioxide and bicarbonate and is found in erythrocytes, platelets, and vascular smooth muscle, all of which contribute to vascular regulation and could be a source of possible CA II-mediated generation of NO from nitrite [16] [17] [18] . Since nitrite exhibits a similar sp 2 geometry as bicarbonate, they hypothesized that CA II acts as a nitrous anhydrase, wherein nitrite binds within the human CA II active site and is dehydrated, analogously to bicarbonate. However, the concept of a CA-nitrous anhydrase activity founders on the problem of how two nitrites can come into close enough proximity in the active site to form N 2 O 3 , which can then homolyze to NO and nitrogen dioxide. With respect to a CA-nitrite reductase activity, the CA coordinated zinc atom retains no redox activity because Zn 2+ has a filled d orbital; rather zinc functions as a Lewis acid to accept a pair of electrons to coordinate a water molecule [19] . This fact presents a problem for any nitrite reductase hypothesis, as no other enzyme has been shown to convert nitrite to NO without redox activity. One possible explanation for their reported NO formation may have been the presence of a contaminating reducing agent present in their CA preparation; perhaps heavy metal atoms such as iron, since the source of their commercial carbonic anhydrase was purified from red blood cells. These metals may themselves act as nitrite reductases through their free electrons.
In our study, generation of NO was not observed upon the addition of NaNO 2 to bovine CA II in the presence or absence of the CA inhibitor dorzolamide. Furthermore, a structural analysis of bovine CA II in complex with dorzolamide showed that the binding of sulfonamidebased CA inhibitors to the catalytic zinc would excludes NO 2 -binding in the active site.
Materials and methods

Biochemical studies
Bovine CA II was purified from red blood cells using affinity chromatography [20] . Enzyme samples were extensively dialyzed against EDTA to remove extraneous metal ions, which can be a source of electron donation for nitrite reduction. The activity of the bovine carbonic anhydrase employed in our experiments was calculated using titration with ethoxzolamide, a sub-nanomolar CA inhibitor. The enzyme was diluted 1:10 and 5 μl of this dilution was added to 5 ml of reaction solution (0.1 M HEPES buffered at pH 7.6). When the enzyme concentration is much greater than the K I of the inhibitor and enzyme is partially inhibited all the inhibitor is bound to enzyme, this yields a straight line on a x-y plot where the y axis is the relative activity of the enzyme (from 0.0 to 1.0) and the x-axis is the concentration of ethoxzolamide. The intercept on the x-axis (inhibitor concentration) was the total enzyme concentration (data not shown). The concentration of NO in solution was measured by membrane inlet mass spectrometry (MIMS), as described in some detail earlier [21, 22] . The inlet probe to the mass spectrometer comprises a 1.0 cm length of silicon rubber tubing (Silastic, Dow Corning) of 1.5 mm inner diameter and 2.0 mm outer diameter, which was sealed at one end by a glass bead. The other end was attached to tubing leading to the inlet to a mass spectrometer (Extrel EXM-200). This allowed continuous measurement of the m/z 30 and m/z 76 peaks, corresponding to NO and dinitrogen trioxide (N 2 O 3 ), as well as concurrent measurement of other dissolved gases such as O 2 and N 2 . Data were collected at an electron impact ionization of 70 eV using an emission current near 1 mA. Source pressures were approximately 1 × 10 −6 mmHg.
A buffered solution at pH 5.9 containing 100 µM bovine CA II was placed in the reaction vessel. NaNO 2 was rapidly injected to a final concentration of 100 µM. Dissolved gases NO, O 2 , and N 2 were detected in the solution phase; NO from the values of m/z 30. After 10 min, the CA inhibitor dorzolamide (Merck & Co) was added at a final concentration of 250 µM. Finally, to show the sensitivity of the procedure, a solution containing dissolved NO was added, resulting in concentrations of up to 25 nM. The solutions containing NO were made by reduction of nitrite using 0.1 M KI in 0.1 M HCl [23] .
An NO electrode of outer diameter 2.0 mm (ISO-NOP, World Precision Instruments) and an NO electrode with fiber tip diameter of 200 µm (ISO-NOPF200, WPI) were connected to a Free Radical Analyzer (TBR4100, WPI) and used for real time detection of the NO. In the experiments using the NO electrode, the data presented are electrode current for solution containing bovine CA II, from which a baseline of electrode current without the addition of BCA was subtracted. This corrected a drift in current which was observed to an identical extent for samples with and without bovine CA II.
The same reaction vessel and reactant solutions were used for the NO electrode and MIMS measurements. The reaction vessel of 5 ml volume allowed insertion of the NO electrode or mass spectrometric probe, as well as insertion of samples and purging of dissolved gases. This was described in some detail previously [21, 24] . The vessel contained a small magnetic stir bar in a sealed reaction vessel, although all solutions were in equilibrium with air. The lower segment of the reaction vessel was submerged in a constant-temperature water bath.
Either the NO electrode or the MIMS probe was inserted into the reaction vessel. Solutions (2.5-5.0 ml) were placed in the reaction vessel. For the mass spectrometric experiments, values of concentration of NO were determined by measuring the area under the m/z peak versus known concentrations of NO, as described previously [21] .
Modeling of the active site of CA II in the presence of dorzolamide and nitrite
An in silico model of bovine CA II in complex with nitrite was generated and analyzed in the graphical program Coot [25] . The binding site and orientation of the nitrite ion within the bovine CA II active site was based upon crystal structures of human CA II in complex with small molecules of similar sp 2 geometry, bicarbonate (PDB: 2VVB) [26] and nitrate (PDB: 1CAN) [27] . Figures were produced in PyMOL [28] .
Results
Our experimental data showed no measurable generation of NO upon the addition of 100 µM NaNO 2 to a solution of 100 µM bovine CA II at pH 5.9 and 37°C. NO production was measured by either mass spectrometry or NO electrode (Fig. 1A and B, respectively) . Furthermore, the addition of the CA inhibitor dorzolamide had no effect on NO production. These experiments were each performed in duplicate utilizing the mass spectrometer and the NO electrode; each method gave identical results. Additional experiments were performed under these conditions increasing the concentration of NaNO 2 to 8 mM, and again no increase in NO was observed. During these experiments, N 2 O 3 generation was also measured via mass spectrometer. No signal was observed at 76 m/z during any of our experiments, indicating no N 2 O 3 production. While it might be argued that carbonic anhydrase itself may scavenge NO, our previous published experiments [21] have shown that generation of NO from nitrite is very similar in suspensions of red cells with their very high CA concentration and in solutions of purified hemoglobin, indicating that carbonic anhydrase does not scavenge NO.
The absence of bovine CA II catalyzed nitrite reductase activity or nitrous anhydrase was further supported by the structural analysis of a nitrite-bound BCA II model (Fig. 2) . Nitrite would be expected to anchor through a hydrogen bond to the zinc-bound catalytic solve molecule (2.7 Å), displacing two water molecules in the active site cavity. Binding of nitrite in this orientation would be further stabilized by a hydrogen bond with the amide of Thr199 (3.3 Å). Our model is supported by the previously observed inhibitory properties of nitrite in the β-CA class Methanobacterium thermoautotrophicum (Cab) and the recent structural studies of sulfonamide CAIs that anchor through the zincbound water [29, 30] .
Discussion
Our results provide no support to the concept that CA generates NO through nitrous anhydrase activity, nitrite reductase activity, or by any other means. Additionally, there is no evidence to suggest that NO production can be enhanced in the presence of a sulfonamide-based CA inhibitor. The conditions used in our experiment were like those reported by Aamand et al. in their original publication that measured NO production with an NO electrode and chemiluminescence. The authors concluded that bovine CA II catalyzes the conversion of nitrite to NO. Their data reported that the addition of 100 µM KNO 2 to a solution containing 100 µM bovine CA II at pH 5.9 and 37°C generated as much as 100 nM of NO, which was further enhanced in the presence of the CA inhibitor, dorzolamide [1] . However, we did not observe any NO generation upon treatment of bovine CA II with various concentrations of NaNO 2 .
Furthermore, we found no evidence of NO generation in the presence of dorzolamide. Adding to our biochemical results, we also studied the interactions of nitrite and dorzolamide in the active site of bovine CA II. The nitrite-bound bovine CA II model superimposed with the crystal structure of human CA II in complex with dorzolamide (PDB: 4M2U) [31] shows that a nitrite ion cannot bind in the vicinity of the zinc in the presence of an inhibitor, such as dorzolamide, due to steric hindrance with the sulfonamide zinc binding group (Fig. 3) .
Our results contradict the findings of Aamand et al. In this regard, we confirm the findings of Liu et al. in their comprehensive study of the mechanisms of red blood cell bioactivation of nitrite; these data provide no support for CA-mediated nitrite reduction or generation of NO by any other means [32] . Using electron paramagnetic resonance at pH 6.8 or 7.4 and 37°C, they demonstrated no nitric oxide generation from intact red blood cells when dorzolamide (100-775 μM) was added to cells incubated with 100 μM nitrite. Additionally, Hanff et al. found no formation of NO in solutions of bovine CA II at pH 7.4 with or without 245 μM dorzolamide, as measured by a NO-sensitive electrode [33] . The surprising finding of Aamand et al. that acetazolamide and dorzolamide paradoxically increased NO generation from NO 2 is difficult to explain since these CA inhibitors block access of nitrite to the zinc or zinc-bound water (Fig. 3) . Aamand et al. argue that CA inhibitor binding may enhance the binding of nitrite elsewhere in the active site and become dehydrated, but do not explain how this is possible when the drugs block bicarbonate dehydration and occupy a significant fraction of the entire active site and its entrance. It would be extremely unlikely that nitrite could bind anywhere else in the complex tertiary structure of CA II and have the necessary local environment to undergo catalytic dehydration. The rationale for the hypothesized role of CA in NO generation (or other bioactive species of NO) is the well-known observation of vasodilation following CA inhibition in isolated blood vessel preparations and under certain situations in vivo (for review see Swenson [34] ). Impairment of CO 2 exit from cells and the body by intracellular and erythrocyte CA inhibition leads to a degree of mild CO 2 retention and hypercapnic acidosis that can be directly vasodilating, but is usually counteracted by increased sympathetic tone. In general, acetazolamide and other CA inhibitors cause little or no blood pressure lowering except in circumstances of heightened tone, such as in hypoxia or in the presence of high concentrations of circulating catecholamines. Acidosis, usually of a magnitude that is rarely present physiologically (< 7.1) yet develops in severely ischemic or hypoxic tissues, can itself cause nitrite reduction to NO by non-catalytic acidic disproportionation.
Other forms of bioactive NO equivalents may be produced from nitrite by enzymatic catalysis, such as dinitrogen trioxide (N 2 O 3 ) or nitrous acid (HNO 2 ). We did not find evidence of N 2 O 3 formation by monitoring the m/z peak 76. If (N 2 O 3 ) could not survive the heat and transit to the mass spectrometer, then its decomposition to NO would have been detected as a peak at m/z 30.
Nitrous acid reaction chemistry remains a possible explanation for a CA-dependent generation of a bioactive NO moiety. CA would serve as a source of protons, via the proton shuttle residue His64 or the zincbound water, to protonate nitrite and generate HNO 2 . Nitrous acid has been shown to spontaneously decompose into NO and NO 2 in aqueous solutions [35] . However, our data indicates that this is very unlikely, since any decomposition of nitrous acid would be visible on the mass spectrometry data as a peak at m/z 30 or 46, which were not detected.
If nitrous acid is generated from BCA II, the most plausible reaction scheme comes from the work done by Hanff et al. Here, they proposed that nitrous acid is the primary CA-catalyzed reaction product of nitrite, which then might undergo immediate nitrosothiol formation with available thiol groups such as glutathione or protein cysteine groups, which are vasodilating or do so by the release of NO. This could occur rapidly enough that NO accumulation would not be detected. In this manner, CA might provide another mechanism for enzymatic generation of a bioactive form of NO in control of vascular tone. However, even this mechanism is unlikely due to the pKa of nitrous acid of 3.4, which is low enough to suppress efficient protonation in bulk solution under physiological conditions, even given the activity of the CA proton shuttle. If this were possible, bovine CA II would easily protonate bicarbonate (pKa 6.4) as well, producing carbonic acid, which is not observed.
In conclusion, our biochemical measurements and modeling of bovine CA II in complex with nitrite and dorzolamide show no evidence that CA II exhibits nitrite reductase activity to generate the NO that may underlie the possible vasodilating effects of acidosis and CA inhibition. Whether other forms of bioactive NO, such as HNO 2 , may be catalytically produced by human CA II or other CA isozymes, including CA IV and other membrane bound isoforms, in the presence of nitrite remains to be better investigated.
